港股午評:指數暴力反彈 恆科指大漲7.71% 恆指上揚近900點
格隆匯11月4日丨市場風險偏好明顯回升,港股低位強勁反彈,三大指數皆大幅拉昇,行業板塊全線拉漲。截止午間收盤,恆指漲5.7%上揚近900點,國指漲6.59%重回5500點,恆生科技指數更是大漲7.71%收復3200點關口。盤面上,昨日市場風向標的權重科技股領銜大市走高,快手漲近14%,京東、阿里巴巴漲超10%,騰訊漲9%收復240港元,網易、百度、美股皆漲超8%;餐飲股、汽車股漲幅靠前,內房股與物管股攜手上漲,體育用品股、手遊股、濠賭股、蘋果概念股等紛紛上揚,大金融股(銀行、券商、保險)上漲助力,市場一片向好。另一方面,生物科技股部分走低,市場細價股普遍下挫,跌幅超10%近30只個股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.